	Effectiveness and Cost-Effectiveness of an App-Based Mindfulness Breast Care Program for Reducing Body Image Distress and Stigma Among Survivors of Breast Cancer: Randomized Controlled Trial. J Med Internet Res Lin H, Zhong Y, Zheng S, Jiang X, Xu Y, Chan S, Liu S, Chow KM, Yang Q, Huang W, Zhu J. PMID: 42061848 [PubMed - indexed for MEDLINE]
	Quantum dots at the oncology interface: Transforming breast cancer diagnosis, imaging, and treatment. Nanomedicine Narula H, Kamal R, Dhiman S, Singh TG, Awasthi A, Dora CP. PMID: 42061545 [PubMed - as supplied by publisher]
	CLO26-109: Evaluation of CDK4/6 Inhibitors-Associated Cardiovascular Events in Breast Cancer Patients: A Retrospective Single Center Real-World Study in Abu Dhabi Emirates. J Natl Compr Canc Netw Alkhawaja D, Oday A, Alawadhi A, Omer L. PMID: 42061457 [PubMed - in process]
	CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform Study. J Natl Compr Canc Netw Sun C, Han Y, Fickel A, Liu L, Lees EH. PMID: 42061454 [PubMed - in process]
	CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy. J Natl Compr Canc Netw Stringer-Reasor E, Li Y, Zhang J, Rocque G, Jones K, O'Sullivan C, Giridhar K, Dees EC, Nanda R, Hunter N, Clark A, Wolff A, Krop I, Lin N, Rimawi MF, Yang ES. PMID: 42061438 [PubMed - in process]
	BIO26-046: Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials. J Natl Compr Canc Netw Shah Z, Aziz S, Haji M, Aslam F, Buradkar A, Baid U, Gandhi S, Kabraji S. PMID: 42061437 [PubMed - in process]
	CLO26-127: Potential Efficacy of Vitamin D in Improving Pathological Complete Response among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Khalid A, Farrukh MT, Usman T, Tahir M, Ahmed AB, Batool A, Mushtaq S, Mohib K. PMID: 42061434 [PubMed - in process]
	Lymph node surgery and CDK4/6 inhibitors in early breast cancer: a pooled analysis from five randomised trials. Lancet Oncol Pfob A, Pham TH, de Boniface J, Gentilini OD, Loibl S, Schneeweiss A, Postma M, van Asselt ADI, Reimer T, Heil J. PMID: 42061372 [PubMed - indexed for MEDLINE]
	CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials. Lancet Oncol Beshr MS, Fahaid A, Shembesh RH, Valachis A, Lambertini M, Cortesi L, Alesawy AF, Abraheem A, Alsharedi M, Ali ME, Elkhanany A, Azim HA Jr, Velikova G, Elhadi M. PMID: 42061371 [PubMed - indexed for MEDLINE]
	Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial. Lancet Oncol Wander SA, Lloyd MR, Keenan JC, Scott EC, Niemierko A, Spring LM, Fell GG, Shin J, Isakoff SJ, Moy B, Ryan L, Padden S, Fisher E, Newton A, Habin KR, Viscosi-Spieler ET, Scarpetti L, Varkaris A, Ellisen LW, Dubash T, Che D, Patel PS, de la Cruz FF, Sutaria DS, Sane RS, Micalizzi DS, Maheswaran S, Haber DA, Juric D, Bardia A. PMID: 42061370 [PubMed - indexed for MEDLINE]
	Beyond diagnosis: Jordanian women's experiences in surgical decision-making for breast cancer. Eur J Oncol Nurs Al-Maaytah NA, Mahasneh D, Alsaraireh AM, Shoqirat N, Al-Oran HM. PMID: 42061183 [PubMed - as supplied by publisher]
	From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2- breast cancer. Breast Stachyra P, Hernando Meliá C, López-Guerrero JA, Gavilá Gregori J, Guerrero-Zotano ÁL. PMID: 42061029 [PubMed - as supplied by publisher]
	Time-Dynamic AI Models to Predict Quality of Life in Patients With Breast Cancer: Development and Validation Study Using the EORTC BALANCE Cohort. J Med Internet Res Hubel NJ, van der Heijden TGW, Murauer B, de Rooij BH, de Ligt KM, Verkooijen HM, Gernaat SA, Hoedjes M, Arndt V, van de Poll-Franse LV, Holzner B, Lehmann J. PMID: 42060909 [PubMed - indexed for MEDLINE]
	Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol Chan JK, Rothe M, Garrett-Mayer E, Pisick E, Ghatalia P, Gregory A, deShazo M, Mileham KF, Murphy MC, Alese OB, Dib EG, Kohler PC, Moyers JT, Mangat PK, Hinshaw DC, Gregory A, Grantham GN, Halabi S, Schilsky RL. PMID: 42060863 [PubMed - indexed for MEDLINE]
	Lipidomic Predictors of Paclitaxel-Induced Peripheral Neuropathy. JCO Precis Oncol Liu Y, Chen CS, Nguyen-Hoang N, Karnovsky A, Henry NL, Stringer KA, Hertz DL. PMID: 42060862 [PubMed - indexed for MEDLINE]
	"Unanswered questions": Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study. PLoS One Laza-Vásquez C, Román M, Delaloge S, De Montgolfier S, Castells X, MyPeBS Executive Committee¶. PMID: 42060634 [PubMed - indexed for MEDLINE]
	Exploring the experiences, challenges, and coping strategies of caregivers of women with Ovarian Cancer: A scoping review. PLoS One Smith GC, Langiano MR, Baek J, Fuller-Thomson E. PMID: 42060564 [PubMed - indexed for MEDLINE]
	Improving Long-Term Adherence to Endocrine Therapy Among Breast Cancer Survivors: Development of a Multiscale Modeling and Intervention System. JMIR Cancer Gonzales Iv M, Garcia-Alcaraz C, Kaur N, Baglione AN, Livermon S, Barnes LE, Wells KJ. PMID: 42060540 [PubMed - indexed for MEDLINE]
	Extracting Quality of Life Information of Patients Diagnosed With Breast Cancer From Health Care Online Forum Posts: Data Feasibility Study. JMIR Cancer Schmidt DM, Schubert R, Chen BP, Kuk D, Kudesia V, Hinz A, Cimiano P. PMID: 42060536 [PubMed - indexed for MEDLINE]
	Multimodality Evaluation of Regional Breast Lymph Nodes: Impact of Expected Changes in the Upcoming BI-RADS Sixth Edition. Radiographics Retson TA, Phillips BC, Fazeli S, Elmi A, Spengler N, Stepenosky JE, Ojeda-Fournier H. PMID: 42060488 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 327983

Page 1 of 16400



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy